William Ringo

William Ringo

Direktor/Vorstandsmitglied bei
Marcadia Biotech, Inc.

Vermögen: 57 115 $ am 31.05.2026

80 Jahre
Health Technology
Finance
Health Services

Profil

William R.
Ringo
is currently Director at Marcadia Biotech, Inc., Non-Executive Director at Atlantic Healthcare Plc since 2017, Director at Indiana University Health Foundation, Inc., Director at Encore Retail GP LLC since 2014, Director at Kovina Therapeutics, Inc. since 2021, and Venture Partner at InCube Venture Partners LLC.
Former roles include President & Chief Executive Officer at Abgenix, Inc. from 2004 to 2006, Non-Executive Chairman & Chief Executive Officer at InterMune, Inc. in 2003, Chairman at Community Health Systems, Inc. from 1994 to 2002, Chairman at Five Prime Therapeutics, Inc. from 2020 to 2021, Chairman at Hyperion Therapeutics, Inc., Chairman at Health Systems, Inc., Chairman at Assembly Biosciences, Inc. from 2015 to 2026, Chairman at Faeth Therapeutics, Inc. from 2022 to 2025, Director at Encysive Pharmaceuticals, Inc. from 2001 to 2007, Director at La Jolla Pharmaceutical Co., Independent Director at Onyx Pharmaceuticals, Inc. from 2011 to 2013, Director at Praecis Pharmaceuticals, Inc., Director at Allos Therapeutics, Inc. from 2007 to 2008, Independent Director at Sangamo Therapeutics, Inc. from 2016 to 2018, Director at Inspire Pharmaceuticals, Inc. from 2001 to 2007, Director at Alvine Pharmaceuticals, Inc., Independent Director at Mirati Therapeutics, Inc. from 2014 to 2016, Director at BioCrossroads, Independent Director at Immune Design Corp.
from 2014 to 2019, Independent Director at Dermira, Inc. from 2014 to 2020, President-Infectious Diseases Business Unit at Eli Lilly & Co. from 1973 to 2001, Senior VP-Strategy & Business Development at Pfizer Inc. from 2008 to 2010, Board Member at Portola Pharmaceuticals LLC from 2006 to 2009, Executive Partner at Sofinnova Investments, Inc. from 2010 to 2011, and Vice President-Sales & Marketing at US Pharmaceuticals, Inc. Education includes undergraduate and MBA degrees from the University of Dayton.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
10.04.2026 1 455 ( 0,01 % ) 40 245 $ 31.05.2026
21.05.2025 798 ( 0 % ) 16 870 $ 31.05.2026

Aktive Positionen von William Ringo

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 28.04.2011
Private Equity Investor -
Encore Retail GP LLC
Direktor/Vorstandsmitglied 20.03.2014
Direktor/Vorstandsmitglied 22.05.2017
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.06.2021

Ehemalige bekannte Positionen von William Ringo

UnternehmenPositionEnde
ASSEMBLY BIOSCIENCES, INC. Vorsitzender 04.06.2026
FAETH THERAPEUTICS, INC. Vorsitzender 02.01.2025
FIVE PRIME THERAPEUTICS, INC. Vorstandsvorsitzender 13.04.2020
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von William Ringo im Detail an

Ausbildung von William Ringo

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

79

Beziehungen ersten Grades

32

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Finance

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Encore Retail GP LLC

Health Technology

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. William Ringo